Have a personal or library account? Click to login
The Diego blood group system-an update Cover

The Diego blood group system-an update

Paid access
|Oct 2020

References

  1. Rohr TE, Smith DF, Zopf DA, Ginsburg V. Leb-active glycolipid in human plasma: measurement by radioimmunoassay. Arch Biochem Biophys 1980; 199:265–9.10.1016/0003-9861(80)90280-5
  2. Crookston MC. Blood group antigens acquired from the plasma. Prog Clin Biol Res 1980;43:99–114.
  3. Marcus DM, Cass LE. Glycosphingolipids with Lewis blood group activity: uptake by human erythrocytes. Science 1969;164:553–5.10.1126/science.164.3879.553
  4. Sneath JS, Sneath PHA. Transformation of the Lewis groups of human red cells. Nature 1955;176:172.10.1038/176172a0
  5. Oriol R, Danilovs J, Lemieux R, Terasaki P, Bernoco D. Lymphocytotoxic definition of combined ABH and Lewis antigens and their transfer from sera to lymphocytes. Hum Immunol 1980; 1:195–205.10.1016/0198-8859(80)90014-2
  6. Dunstan RA, Simpson MB, Rosse WF.Lea blood group antigen on human platelets. Am J Clin Pathol 1985;83:90–4.10.1093/ajcp/83.1.90
  7. Hammar L, Mansson S, Rohr T, et al. Lewis phenotype of erythrocytes and Leb-active glycolipid in serum of pregnant women.Vox Sang 1981;40:27–33.10.1111/j.1423-0410.1981.tb00665.x
  8. Bjork S, Breimer ME, Hansson GG, Karlsson KA. Leffler H. Structures of blood group glycospin golipids of human small intestine. A relation between the expression of fucolipids of epithelial cells and the ABO, Le and Se phenotype of the donor. J Biol chem 1987 :262:6758–65.10.1016/S0021-9258(18)48309-3
  9. Breimer ME, Karlsson K. Samuelsson BE. Characterization of a human intestinal difucosyl beptaglycosylceramide with a blood group B determinant and a type I carbohydrate chain. J Biol Chem 1982:257: 1079–85.10.1016/S0021-9258(19)68310-9
  10. McKibbin JM, Spencer WA, Smith El., Månsson J. Karlsson K. Samuelsson BE, Li Y. Li S. Lewis blood group fucolipids and their isomers from human and canine intestine. J Biol chem 1982;257:755–60.10.1016/S0021-9258(19)68260-8
  11. Smith EL, Bowdler AJ, Bull R.W, McKibbin JM. Human blood group activity of human and canine intestinal glycolipids containing fucose. Immunology 1973; 25:621–9
  12. Henry SM, Samuelsson BE, Oriol R. Immunochemical and immunohistological expression of Lewis histo-blood group antigens in small intestine including individuals of the Le(a+b+) and Le(a-b-) nonsecretor phenotypes. Glycoconj J 1994; 11:600–7.10.1007/BF007313127696864
  13. Henry S, Oriol R, Samuelsson B. Lewis histo-blood group system and associated secretory phenotypes. Vox Sang 1995;69:166–82.10.1111/j.1423-0410.1995.tb02591.x
  14. Gustavsson ML, Gannedahl G, Backer AE, et al. Anticarbohydrate antibodies associated with hyperacute rejection in a vascularized mouse heart-to-rat xenotransplantation model. Transplantation 1996: 61:957–63.10.1097/00007890-199603270-00019
  15. Holgersson J, Breimer ME, Samuelsson BE. Basic biochemistry of cell surface carbohydrates and aspects of the tissue distribution of histo-blood group ABH and related glycosphingolipids. APMIS Suppl 1992;27:18–27.
  16. Oriol R. ABO, Hh, Lewis and secretion. Serology, genetics and tissue distribution. New York: Plenum Press, 1995:37–73.10.1007/978-1-4757-9537-0_2
  17. Karlsson K. Samuelsson BE, Steen GO. Detailed structure of sphingomyelins and ceramides from different regions of bovine kidney with special reference to long-chain bases. Biochim Biophys Acta 1973; 316:336–62.10.1016/0005-2760(73)90073-8
  18. Bouhours JF, Glickman RM. Rat intestinal glycolipids. III. Fatty acids and long chain bases of glycolipids from villus and crypt cells. Biochim Biophys Acta 1977;487:51–60.
  19. Breimer ME, Hansson GC. Karlsson KA, Leffler H. Glycosphingolipids and the differentiation of intestinal epithelium. Exp Cell Res 1981;135:1–1310.1016/0014-4827(81)90293-7
  20. Breimer ME, Hansson. GC, Karlsson K Leffler H. Studies on differentiating epithelial cells of on small intestine. Alterations in the lipophille part of glycosphingololipids during cell migration from crypt to villus tip. Biochim Biophys Acta 1982;710:415–27.10.1016/0005-2760(82)90125-4
  21. Holgersson J, Backer AE. Breimer ME. et al. the blood group B type-1 heptaglycosylceramide is a minor blood group B structure in human B kidneys in contrast to the corresponding A type-4 compound in A kidneys. Structural and in vitro biosynthetic studies. Biochim Biophys Acta 1992;1180:33–43.10.1016/0925-4439(92)90024-H
  22. Larsson H, Carlsson E,Junggren U et al. Inhibition of gastric acid secretion by omeprazole in the dog and rat. Gastroenterology 1983;85:900–7.10.1016/0016-5085(83)90442-0
  23. Larsson H, Mattson H, Sundell G, Carlsson E. Animal pharmocodynamics of omeprazole. A survey of its pharmocological properties in vivo. Scand J Gastroenterol 1985;20:23–35.10.3109/00365528509095817
  24. Good AH, Yau O, Lamontagne LR, Oriol R. Serological and chemical specificities of twelve monoclonal anti-Lea and anti-Leb antibodies. Vox Sang 1992; 62:180–9.
  25. Mollicone R, Bara J, Le Pendu J, Oriol R. Immuno histologic pattern of type 1 (Le1. Leb) and type 2 (X, Y, LI) blood group-related antigens in the human pyloric and duodenal mucosae. Lab Invest 1985;53:219-27.
  26. Karlsson KA. Preparation of total nonacid glycolipids for overlay analysis of receptors for bacteria and viruses and for other studies. Methods Enzymol 1987; 138:212–20.10.1016/0076-6879(87)38018-8
  27. Henry SM, Oriol R, Samuelsson BE. Expression of Lewis histo-blood group glycolipids in the plasma of individuals of Le(a+b+) and partial secretor phenotypes. Glycoconj J 1994; 11:593–910.1007/BF00731311
  28. Hynsjo L, Granberg L, Haurum J; Thiel S, Larson G. Use of factorial experimental design to delineate the strong calcium- and pH-dependent changes in binding of human surfactant protein-A to neutral glycosphingolipids—a model for studies of protein-carbohydrate interactions. Anal Biochem 1995; 225:305–14.10.1006/abio.1995.1159
  29. Holgersson J, Jovall PA, Samuelsson BE, Breimer ME. Structural characterization of non-acid glycosphingolipids in kidneys of single blood group O and A pigs. J Biochem (Tokyo) 1990; 108:766–77.10.1093/oxfordjournals.jbchem.a123279
  30. Henry S, Jovall P Ghardashkhani S, et al. Structural and imunochemical identification of Lea. Leb. H type 1 and related, glycolipids in small intestinal mucosa of a group O Le(a-b-) nonsecretor. Glycoconj J 1997; 209–25.
  31. Henry SM, jovall PA. Ghardashkhani S, Gustavsson MJ, Samuelsson BE. Structural and immunochemical identification of Leb glycolipids in the plasma of a group O Le(a-b-) secretor Glyeoconj J 1995; 12 309–17.10.1007/BF00731334
  32. Breimer ME, Hansson GC, Karlsson KA. Leffler H. Glycolipids of rat small intestine characterization of a novel blood group H-active triglycosylceramide. Biochim Biophys Acta 1980:617:85–96.10.1016/0005-2760(80)90226-X
  33. Breimer ME, Falk K Hansson GC. Karlsson K Structural. identification of two ten-sugar branched chain glycosphingolipids of blood group H type present in epithelial cells of rat small intestine. J Biol Chem 1982;257:50–9.10.1016/S0021-9258(19)68324-9
  34. Gustafsson BE, Karlsson KA, Larson G, et al. Glycosphingolipid patterns of the gastrointestinal tract and feces of germ-free and conventional rats. J Biol Chem 1986;261:15294–300.10.1016/S0021-9258(18)66866-8
  35. Lemieux RU, Baker DA, Weinstein WM, Switzer CM. Artificial antigens. Antibody preparations for the localization of Lewis determinants in tissues. Biochemistry 1981;20:199–205.10.1021/bi00504a0336162479
  36. Lichtenberger LM. The hydrophobic barrier properties of gastrointestinal mucus. Annu Rev Physiol 1995;57:565–83.10.1146/annurev.ph.57.030195.0030257778878
  37. Hills BA, Butler BD, Lichtenberger LM. Gastric mucosal barrier: hydrophobic lining to the lumen of the stomach. Am J Physiol 1983;244:G561–8.10.1152/ajpgi.1983.244.5.G5616846549
  38. Boren T, Falk P, Roth KA, Larson G, Normark S. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 1993:262:1892–5.10.1126/science.8018146
  39. Larson G, Falk P, Hynsjö L, Midtvedt A, Midtvedt T. Faecal excretion of glycosphingolipids of breast-fed and formula-fed infants. Microb Ecol Health Disease 1990;3:305–19.10.3109/08910609009140253
  40. Larson G, Falk E Hoskins LC. Degradation of human intestinal glycosphingolipids by extracellular glycosidases from mucin-degrading bacteria of the human fecal flora. J Biol Chem 1988;263:10790–8.10.1016/S0021-9258(18)38040-2
  41. Baker Hj, Lindsey JR, Weisroth SH. The laboratory rat. In: Biology and diseases. New York: Academic Press, 1979.
  42. Henry SM, Woodfield DG, Samuelsson BE, Oriol R. Plasma and red-cell glycolipid patterns of Le(a+b+) and Le(a+b-) Polynesians as further evidence of the weak secretor gene sem. Vox Sang 1993;65: 62–9.
  43. Henry SM, Oriol R, Samuelsson BE. Detection and characterization of Lewis antigens in plasma of Lewis-negative individuals Evidence of chain extension as a results of reduced fucosyltransferase competiton. Vox Sang 1994;67:387–96.10.1111/j.1423-0410.1994.tb01279.x7701811
DOI: https://doi.org/10.21307/immunohematology-2019-637 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 150 - 158
Published on: Oct 26, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 M.L Gustavsson, R. Oriol, B.E Samuelsson, S.M Henry, published by American National Red Cross
This work is licensed under the Creative Commons License.